Northwest & Ethical Investments’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.09M Sell
20,023
-15,164
-43% -$3.53M 0.12% 132
2026
Q1
$8.59M Sell
35,187
-20,189
-36% -$4.7M 0.2% 119
2025
Q4
$11.5M Sell
55,376
-751
-1% -$149K 0.26% 105
2025
Q3
$10.4M Sell
56,127
-5,400
-9% -$925K 0.25% 114
2025
Q2
$9.4M Buy
61,527
+30,602
+99% +$4.7M 0.23% 124
2025
Q1
$5.13M Sell
30,925
-34,099
-52% -$5.34M 0.14% 172
2024
Q4
$9.4M Buy
65,024
+18,794
+41% +$2.91M 0.26% 129
2024
Q3
$7.49M Sell
46,230
-3,268
-7% -$521K 0.2% 152
2024
Q2
$7.23M Buy
49,498
+8,026
+19% +$1.19M 0.21% 139
2024
Q1
$6.56M Buy
41,472
+15,900
+62% +$2.53M 0.19% 149
2023
Q4
$4.01M Buy
+25,572
New +$3.92M 0.12% 203
2023
Q2
Sell
-25,606
Closed -$3.97M 399
2023
Q1
$3.97M Sell
25,606
-89,176
-78% -$14.4M 0.13% 192
2022
Q4
$20.3M Buy
114,782
+9,445
+9% +$1.63M 0.7% 35
2022
Q3
$17.2M Sell
105,337
-5,230
-5% -$885K 0.69% 36
2022
Q2
$19.6M Buy
110,567
+20,250
+22% +$3.61M 0.74% 35
2022
Q1
$16M Sell
90,317
-9,184
-9% -$1.56M 0.51% 63
2021
Q4
$17M Buy
99,501
+22,050
+28% +$3.61M 0.5% 64
2021
Q3
$12.5M Sell
77,451
-39,438
-34% -$6.73M 0.41% 77
2021
Q2
$19.3M Sell
116,889
-9,751
-8% -$1.61M 0.62% 54
2021
Q1
$20.8M Buy
126,640
+32,422
+34% +$5.25M 0.73% 35
2020
Q4
$14.8M Buy
94,218
+215
+0.2% +$31.7K 0.57% 53
2020
Q3
$14M Sell
94,003
-1,274
-1% -$189K 0.62% 45
2020
Q2
$13.4M Buy
95,277
+10,986
+13% +$1.6M 0.64% 37
2020
Q1
$11.1M Buy
84,291
+53,299
+172% +$7.56M 0.64% 37
2019
Q4
$4.52M Buy
30,992
+17,411
+128% +$2.36M 0.2% 146
2019
Q3
$1.76M Sell
13,581
-28,953
-68% -$3.81M 0.09% 268
2019
Q2
$5.92M Buy
42,534
+7,208
+20% +$998K 0.3% 111
2019
Q1
$4.94M Sell
35,326
-19,842
-36% -$2.66M 0.26% 126
2018
Q4
$7.12M Buy
55,168
+35,708
+183% +$4.98M 0.42% 62
2018
Q3
$2.69M Sell
19,460
-600
-3% -$79.7K 0.17% 178
2018
Q2
$2.43M Sell
20,060
-3,805
-16% -$475K 0.16% 188
2018
Q1
$3.06M Sell
23,865
-1,250
-5% -$169K 0.21% 158
2017
Q4
$3.51M Sell
25,115
-1,415
-5% -$197K 0.23% 137
2017
Q3
$3.46M Buy
26,530
+255
+1% +$33.8K 0.21% 129
2017
Q2
$3.48M Sell
26,275
-2,260
-8% -$288K 0.24% 125
2017
Q1
$3.55M Sell
28,535
-32,610
-53% -$3.9M 0.24% 112
2016
Q4
$7.04M Buy
61,145
+11,575
+23% +$1.34M 0.49% 42
2016
Q3
$5.86M Sell
49,570
-68,790
-58% -$8.35M 0.41% 57
2016
Q2
$14.4M Sell
118,360
-37,760
-24% -$4.29M 1.08% 20
2016
Q1
$16.9M Buy
156,120
+1,200
+0.8% +$124K 1.14% 20
2015
Q4
$15.9M Sell
154,920
-14,560
-9% -$1.46M 1.15% 21
2015
Q3
$15.8M Buy
169,480
+5,200
+3% +$503K 1.22% 20
2015
Q2
$16M Buy
164,280
+66,410
+68% +$6.65M 1.06% 22
2015
Q1
$9.85M Sell
97,870
-24,080
-20% -$2.45M 0.69% 39
2014
Q4
$12.8M Buy
121,950
+40,320
+49% +$4.25M 0.86% 21
2014
Q3
$8.7M Sell
81,630
-4,650
-5% -$482K 0.58% 39
2014
Q2
$9.03M Sell
86,280
-97,000
-53% -$9.8M 0.56% 41
2014
Q1
$18M Buy
183,280
+36,850
+25% +$3.42M 1.18% 18
2013
Q4
$13.4M Sell
146,430
-61,870
-30% -$5.7M 0.89% 28
2013
Q3
$18.1M Sell
208,300
-57,925
-22% -$5.2M 1.31% 15
2013
Q2
$22.9M Buy
+266,225
New +$22.6M 1.79% 13

Other funds holding JNJ

Northwest & Ethical Investments's JNJ Position: Q2 2026 in Review

Northwest & Ethical Investments reduced its Johnson & Johnson (JNJ) stake by 43% in Q2 2026, selling an estimated $3.53M and leaving 20,023 shares worth $5.09M. The position accounts for 0.12% of the portfolio, ranked #132.

Northwest & Ethical Investments first reported a position in JNJ in Q2 2013 and has held it in 51 quarters since. The position peaked at $22.9M in Q2 2013. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Northwest & Ethical Investments held 20,023 shares of Johnson & Johnson worth $5.09M as of Q2 2026.
  • Northwest & Ethical Investments sold 15,164 Johnson & Johnson shares in Q2 2026, an estimated $3.53M.
  • Johnson & Johnson made up 0.12% of Northwest & Ethical Investments's portfolio in Q2 2026, its #132 holding.
  • Northwest & Ethical Investments first reported a position in Johnson & Johnson in Q2 2013 and has held it in 51 quarters since.
  • Northwest & Ethical Investments's Johnson & Johnson position peaked at $22.9M in Q2 2013.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Northwest & Ethical Investments's 13F filing for Q2 2026, filed 13 Aug 2026.